CHX(CHX)
CHX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $3.48B | $3.43B | $4.81B |
| Low | $3.24B | $3.36B | $4.48B |
| High | $3.65B | $3.51B | $5.05B |
| EBITDA Avg | $308M | $304M | $425M |
| Low | $287M | $297M | $397M |
| High | $323M | $310M | $447M |
| EBIT Avg | $41M | $40M | $56M |
| Low | $38M | $39M | $52M |
| High | $43M | $41M | $59M |
| Net Income Avg | $369M | $379M | $602M |
| Low | $353M | $367M | $549M |
| High | $417M | $429M | $641M |
| EPS Avg | $1.93 | $2.08 | $3.11 |
| Low | $1.82 | $1.90 | $2.84 |
| High | $2.16 | $2.21 | $3.31 |
| Analysts (Rev / EPS) | 5 / 2 | 3 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $1.14B | $1.19B |
| Low | $1.14B | $1.19B |
| High | $1.14B | $1.19B |
| EBITDA Avg | $101M | $106M |
| Low | $101M | $106M |
| High | $101M | $106M |
| EBIT Avg | $13M | $14M |
| Low | $13M | $14M |
| High | $13M | $14M |
| Net Income Avg | $99M | $99M |
| Low | $99M | $99M |
| High | $99M | $99M |
| EPS Avg | $0.51 | $0.51 |
| Low | $0.51 | $0.51 |
| High | $0.51 | $0.51 |
| Analysts (Rev / EPS) | 4 / 1 | 2 / 1 |